other groups, such as patients rwscitated from cardiac arrest or with spontaneous sustained ventricular tacbycardia, the induced arrhythmia may be clinically rclcxmt (6-S). Horowitz et al. (6) reported in 1981 that some patients with inducible polymorphic ventricular tachycardia developed uniform ventricular tachywdia when programmed stimulition was repeated after administration of type IA antiarrhythmic drugs. They sueeested that this response was chamcteristic of tachycardias due to reentry and that in such cases, polymorphic tachycavdia was not an artifact of programmed stimulation.
The purpose of the present study was to evaluate systematically the effects of procaioamide (as a prototypical typo 1A atttiarrhytbmic agent) on polymorphic vsntricolar &achy_ cardia induced by programmed stimulation. We postulated that patients in whom programmed stimukdioo induced uniform ventricular tachycardia after procainamide (but ooly polymorphic tachycardia in the absence of antiarrhythmic drugs) should have evidence of anatomic and electrophysiologic substrates most commonly see" with reentrant ve"-tricular tachycardia. These included previous myocardial infarction with extensive left ventricular dysfunction, reproducible initiation and termination of uniform sustaine,: ventricular tachycardia by programmed stimulat;o" and abnormalities of the signal-averaged electrocardiogram (ECG) and left ventricular endocardial activation typically seen in patients with sustainedventriculartachycardia. Inaddition, we explored the potential clinical utility of this response.
Methods
ias& thk response to pro&amide could not he tested (because of allergic history [II = 21 or hypatensio" during intravenous infusion [n = II). The indications for electrophysiologic study included syncope (n = 221, cardiac arrest (n = 36). asymptomatic nonsurtained ventricular tachycardia (n = 6). sustained uniform ventricular tachycardia (n = I I) and miscellaneous conditions MaI tachvcardia. reenStudy paticots. We prospectively studied the effects of procainamide in 79 consecutive patients in whom programmed stimulation in the baseline state induced only wlvmoruhic ventricular tachvcardia. I" three additional tamed ve"tricular tachycardia. Anatomic diises in thex patients included coronary artery disease in 18 (of whom !7 had had a prior myocardiat iofarctio"). cardiomyopathy in 6, valvular disease in 3 and no apparent structural heart disease in 8. This was not a consecutive series of patients. Rather, we attw-*'" 'n %ose pa::icnts sin&i to the patieois with ..~.l" ." ",, uniform ventricular tachycardia induced after procainamida, with respect to the type of heart disease and di preteentation.
Pmtocul. Atier giving written iuformed consent, alI patients uudewent pro8ranuned stimulation after the antiarrhythmic drugs had heen discontinued for at least 5 halflives. This protocol was approved by the University of Pennsylvania Institutional Review Board on September 7, 1976. intracardiac electmgmms. Fmm I to 3 premature e&&n-uli were delivered during a" 8-beat drive during at least two paced cycle lengths (usualty 6Cil and 400 "is) from at least two right ventricular sites. Stimuli were delivered at twice diastolic threshold with use of a pulse width of I ms. The end point for programmed stimulation wa induction of sustained ventricular tachvcardia orcomoletionofthe orotocol withall Programmed stimutatk was perfomxd by using previously described methods and equipment (7). Briefly, thw to five surface ECG leads were recorded simultawouslv with tkt supraventricular tachycardia,~atriai flutter and palpitation; n = 4). Structural heart disease was present in all hut 13 patients. Fiiy-four patients had coronary artery disease, of whom 50 had had a prior myocardial iufarction (~1 month before the study). Heart disease in the remaining patients included cardiomyopathy in six patients, hypertensive cardiovascular disease in three and valvular disease in three. Seventy-eight percent of the patients were me".
To determine whether procaintide would promote it+ duction of uniform ventricular tachycardia in patients with no inducible ventricular tachycardia. we studied a control group of 35 additional patients who I) had no ve"tricular tachvcardia induced bv "mara"""ed stimulation in the ah-3 extrastimuli achieving retiktoriness. &udatio" was stopped in five patients when repmducihie initiation of long (215 compiexes) runs of polymorphic ventricular tachycardia occurred. The same end point was utilized for pmemmmed stimulation in the baseline state and after enxaiuamide.
After completion of the baseline stimulation protocol.
omcaiuamide was administered to a dose of 15 m&z body &i&t at a maximal rate of 50 mglmin. follows by H maintenance infusion at a rate of 0.11 mgkg per mkt. Stimulation was begun S min after the beginning of the maintenance infusion. Serum specimens for pmcainamide levels were obtained at the conclusion of the stinmlatiou se& of antiarrhythn% d&8$, and 2) underwent repeat protocol. programmed stimulation atIer administration of pmcainaSignal-averaged EC& were performed by the method of tide. The owoase of this studv was to determine whether Sin 19) in the absewe ofantiarrhythmic drugs within 48 h . .
unifor"~ ventricular tachycardia induced afwr mainamide of the e<ectrophysiolc& study in Pipatients (61 of 79 study resukd from canvexsion of induced ventricular tachycardia patients and 27 of 35 control patients). Analysis was perfrom a polymotpluc to a uniform pattern or from facilitation formed of IS0 to 200 sinus complexes ushg a 40.Hz high of inductiou of new ventricular tachycardia. We reasoned pass filter. Tracings with noise levels >0.6 ,A were rejected. that ifuniform ventricular tachvcardia induced afterpmcainValues for duration of the filtered QRS X14 ms are considamide was not related to the-polymorphic tachykdia inwed abnomud. Amplitudes of the last 40 ms of the filtered duced in the baseline state. the mevalence of unifor"~ ORS <20 rrV are defined as late potentials. tachycardia after pmzaiaami~e in tlk control group would _ Left vekicular endofardial a&ivatio" was mapped durbe similar to that in the patients with polymorphic tachycariog sinus rhythm in 22 patients by using methods described dia induced at the baseline study. These 35 patients were previously (10.11). studied for evaluation of syncope or presyncope (n = 9), Detinitions. The f&wing definitions were used.
cardiac arrest (n = 8), nansustained ventricular tachycardia Nonsustained venrricular rachycordia = tachycardia last-(n = 10) and exercise-induced sustained ventricular tachying at least 3 beats, terminating spontaneously within 30 S, cardia (n = 3). Five patients were unde.going postoperative and having a rate >toO beat&in. stimulation after subendocardiat resection for recurrent susSustained venrricrdar tmhycardia = tachycardia having a rate > 100 beats/min, lasting >30 s or requiring tem&mtion by pacing or cardioversion in ~30 s because of loss of CO"SCiO"SlRSS.
Polymorphic venrricular rachycardill = tachycardia havine a rate >I00 beats/min. in which the surface ECG morphologic changes continuously (no more than 5 consecutive complexes with the sume morphology, recorded in three or more leads). If sustained, this arrhythmia freauentiv degenerated into ventricular fibrillation. We did not r&n$ todifferentiate between polymorphic ventricular tachycardia and ventricular libriiiation.
Uniform veurriculor tarhycardia = tachycardia in which the surface ECG configuration recxded in three or more leads remains con&w& Lore pofential = root-mean-square voltage of the last 40 ms of the filtered QRS complex <20 PV.
Eleclrogrom cheracteristics. Eiectrograms are characterized as normal, abnormal or fractionated by at least two of three criteria of amplitude, duration and amplitude/duration ratio described previously ~10.11): Abnormal electrograms = eiectrograms with an amplitude <3 mV, a duration >70 ms or an amplitude/duration ratio <0.046. Fracrionared electrograms = electrograms with an amplitude 50.5 mV, a duration 8133 ms or an amplitude/duration ratio r0.005. Lore eleclrogramr = ekctrograms extending beyond the end of the surface QRS complex. Endocardial activation rfme = the interval from the earliest local activation to the latest local activation.
Data analysis. Results of continuous variables are expressed as the mea" vrduc 2 I SD. Comparison of continuous variables was performed by using analysis of variance. Categoric variables were compared by using contingency tables. p values < 0.05 were considered statistically signiticont.
The signal-averaged ECG was analyzed in 51 of the 64 study patients and in 21 of the 27 control patients in whom it was performed. Results in I3 study patients and 6 control patients with bundle branch block or intraventriculer conduction delays al i0 ms were excluded from this analysis.
ReSUltS
The 79 study patients by definition had xly polymorphic ventricular tachycardia without any uniionn ventricular tachycardia induced at the baseline eiectrophysioiogic study. The induced polymorphic tachycardia was sustained in 38 patients: in the remaining 41, only nonsustained tachycardia was induced. The cycle length of the induced poly. morphic tachycardia usually varied from boat to beat (range 170 to 230 ms). Induction of the polymorphic tachycardia was reproducible (induced ~-2 times) in 67 of the ?I patients in whom reproduction of the arrhythmia was attempted. Reproduction of the arrhythmia was not attempted in eight patients with sustained induced polymorphic tachycardia thet required cardioversion.
Response to prctpmmed stimulation after pmeatnamtde. The 79 patients were then classified into three groups BE. cording to the response to programmed stimulation after Qrocainamide. Group I consisted of 24 patients in whom uniform ventricular tachycerdia was induced after procainamide (Fig, 1) . The uniform tachycardia was sustained in 18 patients; in the remaining 6, only nonsustained uniform tachycardia wes induced. The mean cycle length of the induced uniform tachycardia was 294 * 42 ms. Twelve-lead ECGs of spontaneous suslained ventricular tachycardia were available in three Grouo L vatients. The confimuation of uniform ventricular tach&&a induced after &ain-amide did not match that of the spontaneous ventricular tachywdia in any of these three. Induction of the uniform tachycardia was reproducible in IS of the 18 patients in whom repxduction of the arrhythmia was attempted. Reproduction of the induced ventricular tachycardia was not attempted in the remaining six patients btcmse the indxcd tachycardia caused loss of consciousness requiring cardioversion. The induced sustained ventricular tachycardia was tetinated bv overdrive pacing or extmstimuli in IS of 18 patients. Five of these patients had developed the spontaneous arrhythoda while receiving empiric annarhythmic therapy (quinidine in three, procainamide in one and tocainide in OllC).
Group 7 c.nsisted d 30 patients in whom induction of polymorphic ventticuia tachycadia persisted after procainamide admoxdstration. The induced tachycardias were sustained in 9 patients; only nonsustained tachywdia was induced in the remaining 21. The mode of ventricular tachycardia induction was onchaoSed in 21 patients after procainamide, whereas induction reqoired one more extrastimulus in 7 patients and one less extrastimulus in 2 patients. One patient had previously developed spontaneous ventricular tachycardis while receiving pmcainamide and lidomine. Group 3 consisted of the remaining 25 patients in whom no ventricular mchycardia was inducible after pmcainamide administmtioo. Three of these patients had experienced cardiac arrest while receiving mdnidbx (n = 2) or disownmide (n = I).
. Clbll&Chulo*rbtlesIldtypesOfbeut~~The ages of patients were similarforallgmups (Table I ). Patients in Group 1 were signbicaatly less likely to he female than were those in Group 2 or 3 (Table 1) . However, when patients with coronary disease only were analyzed, there was no sign&ant diierence in the distribution of gender across the~goups. The pmcainamide levels attained during the rlectrophysiologic study in each group were similar (Tabie I). in 36 cases, pmc.~inamide levels were obtained 5 min after the start of the maintenance infusion (just before the initiation of programmed stimulation) and at the end of the stimulation protocol. The mean dierence between the prcainamide levels before and at&r stimulation in these. 36 patients was 1.9 &liter (range 0.1 to 3.6).
Polymorphic ventrkwlar tachycardia was induced io 28% of patients by extrastimuli more premature than I80 ms. However, it was induced by such an extrasiimulus in only 2 Group I patients in contrast to 11 Group 2 patients and 8
Group 3 patients (p = 0.034). The coopliog interval of the most premature extrastimulus required to induce pdymorphic ventricular tachycardia was sigoiiicaotly longer for Group 1 patients (193.8 2 17.1 ms) thao that for Group 3 patients (176.8 f 21.2 ms, p = 0.019) but not than that for Group 2 patients (184.5 f 21.0 ms). There was no differera among the three grwps with respect to the duration or cycle length of induced polymor&ic tachycwdias.
The clinical presentations and types and extent of underlying heart disease differed sigolfwmlly among the three goups (Tables 2 and 3 ). The prevalence of coronary artery disease was sbgiliantly higher in Group 1 patients than in either Groop 2 or Group3 patients. Tweoty-three(% Group I patients had coronary artery aisease compared with only 63% of Group 2 p&MS and only 489% of Gmup 3 patients @ = 0X13). Similarly, patients in Group I were more likely to have experienced a previous myoxdial infarction (96% vs. 53% of patients in Group 2 and 48% of patients in Group 3, p = 0.00s).
Patients in Group I differed signi&ntly from those in Groups 2 and 3 with regard to variables of left ventricular anatomy and function. Forty-six percent of Group I patients had a I& ventricoku aneurysm compared with 13% and 0% of Gmup 2 and 3 patients, respectively @ = O.OW2). The mean left ventricular ejectkm fraction was also signiftcantly lower in Group 1 patients than in patients in either of the other two 8roops (p = 0.019) ( Table 2 ). These differences in (Table 3) .
Siglucnveraqed eleetreardicgnpby and eleetmphyaobgie and mapping stodiw. The characteristics of the sigoalaveraged electrocardiogram were also different for Group 1 thao for Groaps 2 and 3 (Table 4) To analyze the results of the left ventricular wtivation maps WC combined Gmops 2 and 3 because the patients in these two groups were so similar in all other variables, and because of the relatively smell number of patients in whom left ventricular activation maps were performed. Seven patients in Group I ooderweot mapping compared with 15 patients in combined Gmops 2 attd 3. Ihc number of sites mapped was similar for each (Table 5) . 'IIe percent of sites with abnomtal electmgrams, fractionated electrogtams and late electmgrams was greater for the ~&cots developing uniform venlricul~ tachycardia atIer procaioamide, but the difference achieved statistical significance only for the percent of rites with fractionated electmgrams because of the small number of patients analyzed (Table 5 ). The cndocwdial activation time was slightly longer for Group I. and the domtioo of the longest local electrograttt was signilicatttly greater for Group 1 patients (Table 5) .
The mean pmcainamide level achieved during the cleetrophysiologic study in the control group without inducible ventdcular tachycardia at the baseline study was 9.7 mg/iiter (p = NS vs. Group I). Programmed stimulation after procainamide administration in this group revealed inducible ventriculartachyahmias in 5 ofthe 35 patients (ventricular fibrillation or flutter in 2 patients and monomorphic tachycwdii in 3). The monomorphic ventricular tachycardias included bundle branch reentry in one patient with dilated cardiomyopathy and uniform ventricular tachycwdia having a cycle length of 400 and 320 ms, respectively, in the remaining two patients with coronary disease. One of these patients was undergoing programmed stimulation ior evaluation of the results of subendocardial resecttoo for uniform ver~tricular tachycardia. The other patient was undergoing an ekctrophysiologic study to evaluate 1~1 episode of sustained ventricular tachycardia that precipitated cardiac arrest during empiric therapy with encainide. The rate of inducible unifono ventricular tachycardia after procainamide in patients with coronary disease and polymorphic ventricular tachycardia induced at the baseline sttiy (23 of 54) is sigoifc~ntly higher tkn this rate in patients with no ventricular tachycardia induced at the baseline study (2 of 18). The mea" left ventricular ejection fi.c&n in this gmup of 34% was similar to the mean ejection frac!ion of Group 1 but signiIicantly less than that of Group 2 or 3 ( Table 2 ). The sipnai-averaged ECG variables in the control patients were &tiler to those in Groups 2 and 3 and significantly ditferent horn those of Group I an average. That is. the mean filtered QRS duration was only 100.9 ms, and only 2 of 21 patients had an abwmtally pmlcnged QRS duration. Late potentials were present in only 3 of the 24 control patients (without inducible ventricular tachycardia at the baseline study) for whom the signal-averaged ECG could be interpreted.
Treatmat and fdlow-nap. In Group I patients, treatment vm iodividualized on the basis of clinical presentation and the unifom~ tachycardias induced in the presence of procainamide (sod in many cases, other antiarrhythmic agents, too). The monomorphic sustained ventriculartachycardia induced in the presence of procainamide formed the basis for performing activation mapping-guided subendocardial resection in fo"r patients (two had presented with cardiac arrest ad two had presented with stable monomorphic sustained ventricular tachycardia). After surgery, pmgrammed srimulalion faded to induce uniform and polymorphic ventricular duced ventricular tachycardii. Two of these three also received an implant&k cardioverterdefibriilator (two had preqented with sustained uniform ventricular achy&k, and one with cardii arrest). Two patients underwent myocardial revascularization (one had presented with cardiac arrest. the other with sustaimd ventricular tachycardia and angina). The last live patients in this group were discharged with no antiarrhythmic therapy. After a "teaa foRoow-"p interval of 40 months (mope 17 to 87). two of these lrve patients experienced sudden cardii death. One patient originally presented with sustained ventricular taehycardia. the other with a cardiac arrest; both were discbarged with ven!ricular tachycardia persistently inducibie with amkdarone. The five patients discharged with no atttiar~hytbmic therapy (because of infrequent, nonlife-threatening arrbylhmiss) 81 alive and well. Two patients were lost to follow-up.
Group 2 patienrs with p~lymwpbic ventricular taehycar. die persistently inducible after p&de were treated primarily on the bads of their origkl clinical preseotatiw. Coronary artery bypass grafting was performed in fozz patients (all had presented with cardiac arrest). Implantation of a cardiovenerdelibrillator was performed in seven pa tients, six of whom had presented with cardiac arrest. and one with syncope. Thkteett patients received pltamzol~ atttiarrhythmic therapy. In five patierds phamtacologic therapy was given as a" adjunct to an implanted caniiwerterdefibrillator. In the other eight patients pharmafolagic tberspy alone wet adzkistzed (four had presented with cardiac arrest, three with syocopz and o"e with atrial titter with aberrant intraveatricular cwduction). Eleven patients were discharged with no aotiarrhytic therapy: three had presented with syncope, hve witlt asymptomatic no"sustaioed ventricular tachycardii and one each with s"prave"tricular tachycardia, cardiac awest and v.wricular tachycardia while receiving antiarthythmic therapy. After a "tea" follow-up period of 37 months (range 2 to I1 I months. we patient lost to follow-up). one patient who had been treated by myocardial revaxularizatio" expetieoeed a rearrest cardiac arrest from which he was resuscitated.
Group 3porienfs (with polymorphic ve"tricular tachycardia "a longer inducible after pnxainamide) were treated an the basis of clinical presentation and results of elecbophysiologic studies. One patient *ho had presented with vcotric-"lar tachycardia early after acute myocardial infarcticm tachycardia in all four cases. Pharmacologic antiarrhythmic underwent coronary attery bypass gr&ittg and was given therapy rendered ventricular tachycardia (both uniform and procainamide. Nine patients were given ~b~acologic adpolyinot'pbic) noninducible in two patients, and they were &rhythmic therapy ihat eliminated indkible polymot@ic discbarged on these regimens. Phamtacologic therapy reventticular tachwrdia (four presented with cardiac arrest, staled in persistently inducible uniform hut hemodynamithree with sy&pe, one with palpitation and one with tally stable sustained ventriculat tachywdia in eight pauniform ventricular tachycardia early after aortic valve tients, and they were discharged on these regimens. replacement). The remaining I5 patients were given no Sustained unifon" ventricular tachycardia remained inducantisrrhythmic therapy. After a mean follow-up period Of 41 ible and he"mdynamicaUy unstable after multiple drug trials months (range 3 to s4), three patients had experienced in three patients. Au were discharged on the pharmacologic rec"rrettt car&a arrest. all of whom were discharged withr&men that made induction most "diBc"lt" (rewired the o"t inducible ventricular tachycardia on treatment with m&t extrastimuli) and caused the greatest sl&& of inprwainamide.
Discussion the induced polymorphic ventricular tachycardia and to alter
This study has demonstrated that cowrsion of inducible c&morphic ventricular tachycardia into inducible uniform . . ventricular tachycardia after procainamide is not rare: aporoaimatelv 30% (24 of the 79) oatients studied exhibited this . nommlities similar to those found in patients with spontaneresponse. Our analysis sugg.&s that this response OCCIUS ous and inducible uniform ventricular tachycardia (12).
almost exclusively in patients with coronary artery disease and orior mvocardial infarction with sirmiticaot ventricular Finally, subendocardial resection, guided by activation map dysf;nction who have experienced sp&meous sustained ~entri~ult~ tachyarrhythmias. The majority of these patients exhibited abno..nalities of the signal-averaged ECG typical of those of patients with spontaneous monomorphic ventricular tachycardia, that is, abnomnlly prolonged filtered QU8 durations and a high prevalence of "late potentials." Parthermore, the left ventricular sinus rhythm maps in Group 1 showed ~&LX of extensive endowdial conduction abcharacteristics of a "latent" reentrant circuit responsible for the uniform ventricular tachycardia, permitting its expression in response to programmed stimulation. To examine the ooifom~ Ad polymorphic ve&icolar tachy&dia were no latteroassibilitv. we evaluated the ~esconse to procainamide in tbebatients who had no ventricular iachyc&a induced in longer inducible in these four patients. Facilitation of bundle the baseline state. Oolv 6% (2 of 35) of patients in this moop branch reentry, 88 we observed in one patient, has been had inducible uniform~ent~cular tach&dia after p&xii-amide administration. This observation suggests that the latter mechanism may have accounted for some of the responses observed in Group I patients but was probably not resoonsible for most of these responses or the rate nf inducible uniform ventricular tach&rdia in the control erouo would have been closer to the 32% observed in the I . study group. Furthem~ore, four Group 1 patients underwent activation mapping-guided subendocadial resection for their monomorohic veotriculwtachvcardia. Postoperatively, both ping of the induced uniform tachycardia in four patients, described previously, and appears to result prbnarily from resulted in cure of both the uniform and the polymorphic slowing of conduction in the His-Porkinje system after tachycardias. Thus, the patients developing inducible unipro&amide (13). form ventricular tachycardia atler procainamide had the The characteristics of patients with persistent inducible typical substrates seen in patients with reentrant sustained polymorphic ventricular taehycardia verses those without ventricular tachycardia.
inducible tachycardia after procabmmide did not ditTer. Inducible polymorphic tachycardia was converted to uniPatients in these tsvo groups (Groups 2 and 3) were similar fom, ventricular tachycardia after pmcainamide in 31% (II with regard to clinical presentation and type and extent of of 36) of patients undergoing evaluation for a cardiac arrest, underlying heart disease as reflected by left ventricular in 14% (3 of 22) of oatients evaluated for wncope and in 72% ejection fraction. The greater likelihood of Group 3 patients (8 of il) of 'ti&e evaluated for sponia"e& sustained useful in eval&iog the clinical significance of'indwed polymorphic ventricular tachycardia and in guiding therapy. ventricular tachvcardia. We believe that this reswnse is This is best exemplified by the four patients who underwent activation map-guided surgical resection, resulting in cure of both inducible uniform and polymorphic ventricular tachy. cardia. However, the clinical implications of failure of induced tachycardia to become uniform are difficult to determine because treatment was necessarily individualized. Clearly, abolition of inducible polymorphic ventricular tachycardia by procaioamide (the Gioop 3 response) cannot be taken as a favorable response because three of four patients treated pharmacologicaUy who had presented with cardiac arrest experienced rworrent cardiac arrest. This rate of recurrence is significantly higher !ban that observed in Group I patients (I of II).
origin of the ventricular tachycardiaor effects at the site of 10 require 3 extrastim& to induce polynorphic ventricular stimulatioo or intervening tissue, or both.
tachvcardia is compatible with dw effecects at the sits of Our observations extend those of Horowitz et rd. (6) , who suggested that inducible polymmpbic ventricular tachycardia occurs in home cases on the basis of reentry witbin the myocardium. Our patients had no evidence of a prolonged QT interval ivhen studied in the absence of antiarrhythmic drugs and none had evidence of a long QT interval after administration of intravenous procainamide. Although Horowitz et al. (6) termed their patients' arrhythmia "torsade de pointes," they recognized that this rhythm was not the classic "torsade" described by Dessertennes. Because recent information suggesting that torsade de pointes in association with a prolonged QT interval is due to early afterdepolarizations, we believe that the arrhythmias observed in the current study and that of Horowitz et al. are more properly termed "polymorphic ventricular tachycardia." The ability to reproducibly initiate and terminate the Mecbantsm of tacbyea& cenversIon. The mechanism underlying the apparent conversion of polymorphic vent+ ular tachycardia to the uniform tachycardias is less clear from this study. It seems most likely that the polymorphic majority of unifom~ tachycerdias by programmed stimulavenbicslar tachycardias induced in the baseline state in tion is most consistent with a reentrant mechanism. Atso Group I patients were slowed by procainamide, permitting consistent with reentry is the observation of abnormalities of expression of a uniform tachycardia contigoration after endowdial acttvation: slow local conduction and delayed procalnamide. It is also possible that the effect of pmcainglobal activation revealed by the sinus rhythm maps. Alamide administration in the Group 1 patients was to abolish though the relatively small number of patients who underwent mapping precluded attaining statistical significance for most of the observations, there was considerable consistency in the measurements. All the variables measured were more abnormal in patients with inducible uniform ventricular tachycardia. In addition, the percent of abnormal, fractionated and late electrograms were very similar to those observed in patients with spontaneous and inducible uniform sustained ventricular tachycardia in other studies (12). Hunt and Ross (14) recently reported observations similar to ours in 8 dog model of myocardial infarction. After observing conversion of polymorphic induced ventricular tachycardia to uniform (induced) ventricular tachycardia after pmcainamide in six of nine anlmals, they suggested that this effect represented a "pmarrhythmic" manifestation of procainamide. We hesitate to draw a similar conclusion from our data because the spontaneous arrhythmias in the majority of our patients had developed in the absence of antiarrhythmic drugs. Of the 24 patients who had inducible uniform ventricular tachycardia after pmcainamide administration, only 5 had had their prior spontaneous arrhythmias while receiving antiarrhythmic drugs (2 patients with cardiac arrest and 1 patient with syncope during treatment with quinidine, and 2 patients who had sustained monomorphic ventricular tachycardia while receiving tocainide or prcainamide, respectively). In none of these caw did the spontaneous event appear to be related to a drug-induced long QT syndrome. while these patients' spontaneous arrhythmias did not occur in the presence of pmcainamide, we believe that it is premature to conclude that the observed effects in the electmphysiology laboratory represent "pmarrhythmia." However, it is possible that if our patients developing uniform ventricular tachycardia after procninamidc wnre discharged on treatment with this agent, they might have an increased frequency of spontaneous episodes or some other possible "pmarrhythmic" effect. Au et al. (IS) also observed the induction of uniform ventricular tachycardia after administration of type IA agents in 2 of I4 patients without inducible tacbycardia in the baseline state and in 2 of 10 patients with nonsustained polymorphic ventricular tachycardia at the baseline study. They also considered these findings to represent "proarrhythmic" responses. However, none of their patients had previously experienced spontancaus symptomatic arrhythmiss. We hesitate to classify such respanxs as pmarrhythmic in the absence of any clinical correlation. the spontaneous ventricular tachycardia. Although the morphclogy of sostzined ventricular tachywdia induced after pmcainamide did not match that observed spontaneously in 3 cases. this is oat unusual, as anttiythmic agents often alter the morphology ofspaotane~us and indueedvearicular tachycxdia. It is also important to remember that the patient population studied here is heterogeneous. Altlwugb the majority had coronary artery disease, espwiaUy among the patients that developed uniform venhiculartachycardiaafter urocainamide, it is diUicult to be certain of the si!&cance of ihe procainamide response in patients with &ischemic heart disease.
Clinical impt~. In summary, our obwwatbns auggest that in patients undergoing electmphysidogic study for evaluation of clinical ventricular tachyarrhytbmias, when only polymorphic ventricular tachycardia is induced at the baseline study. repeat study in the presence of an antiarrhythmic drug such as pmcainamide may prove useful in guiding antiarrhythmic therapy. This response is especially likely to occur in patients with coronary artery disease and prior myocardial infarction and may facilitate induction of bundle branch reentrant tachycardia. Our observations suggest that abolition of inducible polymorphic ventricular tachycardia by prcama&te is not a clinically relevant or useful response.
Limi(sttom of the sh&. There are several limitations to this study. Because we do not have ECG documentation at the c&of cardiac arrest or apisodesof syncope. we cannot be certain tbzt the uniform tachycardia induced after procainamide in patients who were evaluated after syncope or cardiac arrest was responsible for the spontaneous arrhythmiss. In addition. we don't have ver%cation in all cases of the morphology on ILlead electrocardiograms of spontaneous sustained ventricuIar tachyctiia, and therefore. cannot be certain that the morphology of uniform ventricular tachycardia indwexi after procainamide was the same as that of
